Cardiogenic Shock: Customized Therapeutic Approaches in 2023
Presenter:
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- I have received research support from Abbott - Abbott Vascular
- Scientific Advisory Board Member - Abiomed
- Grant Support/Research Contract - Verantos
- Consultant Fee/Honoraria/Speaker's Bureau - NuPulseCV
Video Player is loading.